Skip to main content
ILC Therapeutics home page
  • About us
    • Overview
    • Senior Management
    • Board of Directors
    • Investors
  • Platform
    • Background
    • Hybrid interferons
  • Our pipeline
    • Alfacyte™
  • News and events
    • Press releases
    • Newsroom
  • Contact

Contact

Contact us

  • +44 (0) 141 255 1038
  • contact@ilctherapeutics.com
  • Suite 2, Ground Floor Orchard Brae House, 30 Queensferry Road, Edinburgh, United Kingdom, EH4 2HS
ILC Therapeutics home page

ILC Therapeutics is a specialist UK-based developer of hybrid interferons, a new engineered drug class with improved therapeutic profiles.

Linkedin

Navigation

  • About us
    • Overview
    • Senior Management
    • Board of Directors
    • Investors
  • Platform
    • Background
    • Hybrid interferons
  • Our pipeline
    • Alfacyte™
  • News and events
    • Press releases
    • Newsroom
  • Contact

Find Us

ILC Therapeutics Ltd.
100 West George Street
Glasgow
G2 1PP

See on map

Contact Us

  • +44 (0) 141 255 1038
  • contact@ilctherapeutics.com

© ILC Therapeutics — All rights reserved